(WCH) Wacker Chemie - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000WCH8881
WCH: Silicones, Polymers, Biosolutions, Polysilicon
Wacker Chemie AG, a German-based multinational chemical company, stands as a prominent player in the specialty chemicals sector. With a rich history tracing back to its founding in 1914, Wacker Chemie has established itself through four distinct divisions, each catering to diverse industrial needs.
The Wacker Silicones division is pivotal, offering an array of products such as silanes and silicone fluids. These are integral in electronics manufacturing and construction, where durability and thermal resistance are paramount. The divisions contributions are evident in the production of resilient materials used across various applications.
Wacker Polymers excels in providing binders and polymeric additives, essential in construction and adhesive industries. Their innovations enhance the performance of materials, making them crucial for modern construction projects that demand high strength and flexibility.
Within the realm of biotechnology, Wacker Biosolutions offers customized products that are vital for pharmaceuticals and food additives. This division underscores the companys commitment to advancing health and nutrition through cutting-edge biotech solutions.
Wacker Polysilicon serves the semiconductor and solar sectors with hyperpure polysilicon, a critical component in the production of solar panels and electronic chips. This division highlights the companys role in supporting renewable energy and technological advancements.
From a financial perspective, Wacker Chemie AG presents an intriguing profile with a market capitalization of 3561.27M EUR. The P/E ratio of 27.52 and forward P/E of 21.93 suggest expectations of continued growth. A P/B ratio of 0.77 indicates a reasonable valuation relative to its book value, while the P/S ratio of 0.62 reflects a modest revenue multiple.
In summary, Wacker Chemie AGs diverse divisions and strategic role in key industries make it a notable entity for investors seeking exposure to the specialty chemicals sector. Its historical legacy, combined with forward-looking innovations, positions it as a significant contributor to both industrial and technological progress.
Additional Sources for WCH Stock
WCH Stock Overview
Market Cap in USD | 4,361m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception |
WCH Stock Ratings
Growth 5y | 6.83% |
Fundamental | 7.94% |
Dividend | 67.1% |
Rel. Strength | -26 |
Analysts | - |
Fair Price Momentum | 65.22 EUR |
Fair Price DCF | - |
WCH Dividends
Dividend Yield 12m | 7.06% |
Yield on Cost 5y | 14.75% |
Annual Growth 5y | 0.00% |
Payout Consistency | 81.6% |
WCH Growth Ratios
Growth Correlation 3m | 80.6% |
Growth Correlation 12m | -85.7% |
Growth Correlation 5y | 5% |
CAGR 5y | 13.92% |
CAGR/Max DD 5y | 0.22 |
Sharpe Ratio 12m | -1.38 |
Alpha | -46.13 |
Beta | 1.263 |
Volatility | 39.79% |
Current Volume | 181.9k |
Average Volume 20d | 183.7k |
As of April 03, 2025, the stock is trading at EUR 72.18 with a total of 181,913 shares traded.
Over the past week, the price has changed by -10.45%, over one month by +5.31%, over three months by +2.59% and over the past year by -28.88%.
Neither. Based on ValueRay Fundamental Analyses, Wacker Chemie is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 7.94 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WCH as of April 2025 is 65.22. This means that WCH is currently overvalued and has a potential downside of -9.64%.
Wacker Chemie has no consensus analysts rating.
According to ValueRays Forecast Model, WCH Wacker Chemie will be worth about 74.9 in April 2026. The stock is currently trading at 72.18. This means that the stock has a potential upside of +3.74%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 93.8 | 30% |
Analysts Target Price | - | - |
ValueRay Target Price | 74.9 | 3.7% |